The overexpression of IF1 is a common feature of many human cancers and has been proposed to be a pivotal mechanism to drive the nuclear retrograde response, ensuring metabolic adaptation, survival, and proliferation of cancer cells (Formentini, Sánchez‐Aragó, Sánchez‐Cenizo, & Cuezva, 2012). This evidence concerns the gene ATP5IF1 and cancer.